Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs ...Middle East

HONG KONG, Feb. 24, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that its partner on ivonescimab, Summit Therapeutics Inc. (NASDAQ: SMMT) has entered into a clinical trial collaboration with Pfizer Inc. (NYSE: PFE) to evaluate ivonescimab, a novel,...

Read More Details
Finally We wish PressBee provided you with enough information of ( Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs )

Also on site :

• This Common Over-the-Counter Medication May Harm Brain Health, Doctors Say—Do You Take It?
• Explosion at fireworks factory in China kills 9, state media says
• In Q1 2025, enterprise SaaS M&A deal count hit 210, according to PitchBook